Etana is a privately-owned company established by Indonesian and international investors, including:

Legend Capital

Legend Capital, founded in April 2001, is one of the longest established and leading Venture Capitalist and Growth manager in China and a member of Legend Holdings. Legend Capital started investing in the healthcare sector since 2007, and is one of China's pioneers in this space. Over the years, the fund has grown its expertise and has built a fully functioning healthcare ecosystem that generates potential collaboration and integration opportunities across portfolio companies. Legend Capital has made approximately 120 investments across the healthcare ecosystem, and boasts more than 20 public companies that are now leaders in innovative therapeutics, biotechnology, medical devices, diagnostic technologies, medical services and digital healthcare sectors.

UOB Venture Management Pte Ltd

UOB Venture Management Private Limited (UOBVM) is a wholly-owned subsidiary of United Overseas Bank Limited (UOB), a leading bank in Asia with a global network of around 500 branches and offices. UOB is rated among the world’s top banks: Aa1 by Moody’s Investors Service and AA- by both S&P Global Ratings and Fitch Ratings. Since 1992, UOBVM has been providing financing to privately-held companies in Southeast Asia and Greater China through direct equity investment. UOBVM advocates responsible investing through impact investments and integrating ESG (environmental, social and governance) considerations into its investment process. UOBVM is a signatory of the Operating Principles for Impact Management and the United Nations-supported Principles for Responsible Investment. UOBVM is the fund manager for the Asia Impact Investment Fund series with Credit Suisse as its impact advisor. UOBVM has assets under management in excess of S$2 billion.

Innovent Biologics, Inc.

Established in 2011, Innovent is committed to developing, manufacturing, and commercializing high-quality, affordable and innovative biopharmaceutical products for the treatment of cancer, autoimmune, metabolic and other major diseases. Innovent was listed on the Main Board of the Stock Exchange of Hong Kong Limited in 2018.

China Medical System

China Medical System Holdings Limited ("CMS", together with its subsidiaries, the "Group") was established on year 1995, it is an innovation-driven specialty pharma with a focus on sales and marketing in China and expanding to South East Asia in recent years, dedicated to offering competitive products and services to meet unmet needs for health and beauty in the region.

Since 2010, the Group has been listed on the Main Board of the Stock Exchange of Hong Kong Limited.

Yunfeng Capital

Yunfeng Capital is a leading private equity investment firm in China committed to fostering future-ready companies. With a common vision for building a better future, we work side by side with entrepreneurs to create long-term value.

We have formed deep sector expertise and industry insights in our focused sectors, including Technology, Business Services, Green Energy, Digital Agriculture, Biotechnology and Consumption, and we are dedicated to promoting technological innovation and sustainable development to enable and to drive industry transformation and upgrade.

HighLight Capital (HLC)

HLC is an investment company with a mission to promote technology innovations based on deep scientific and industrial insights. We focus on enabling high growth sectors such as healthcare, biotech and consumer, and we strive to create long-term value and deliver life wellness.

HLC currently manages RMB & USD funds, with offices in Shanghai, Beijing and Shenzhen.

DEG

For more than 60 years, DEG has been financing and advising private enterprises operating in developing and emerging-market countries. With a portfolio of around EUR 9.9 billion we’re one of the world’s largest private-sector development financiers. As an impact and climate investor we accompany companies that are addressing transformation and aiming to seize their opportunities. Our customers not only receive financing and advisory solutions tailored to their needs: they can build on our market knowledge, our impact and climate expertise and our international network. In this way, we contribute together to creating more skilled jobs and local income and to improving value creation on the ground in line with the SDGs. Learn more: www.deginvest.de

East Ventures

East Ventures is a pioneering and leading sector-agnostic venture capital firm. Founded in 2009, East Ventures has transformed into a holistic platform that provides multi-stage investment, from Seed to Growth stage investments, for over 250 tech companies across Southeast Asia.

As an early believer in the startup ecosystem in Indonesia, East Ventures is the first investor of Indonesia's unicorn companies, namely Tokopedia and Traveloka. Other notable companies in East Ventures’portfolio include Ruangguru, SIRCLO, Kudo (acquired by Grab), Loket (acquired by Gojek), Tech in Asia, Xendit, IDN Media, MokaPOS (acquired by Gojek), ShopBack, KoinWorks, Waresix, and Sociolla.

East Ventures was named the most consistent top performing VC fund globally by Preqin, and the most active investor in SEA and Indonesia by various media. Moreover, East Ventures is the first venture capital firm in Indonesia to sign the Principles of Responsible Investment (PRI) supported by the United Nations (UN). East Ventures is committed to achieving sustainable development and bringing positive impacts to society through its initiatives and ESG-embedded practices.